Leaflet TEDOCAD 20mg / 0.5ml concentrate+solvent for solution for infusion


Indicated for: cancer

Route of administration: infusion

Substance: docetaxel (taxane antineoplastic)

ATC: L01CD02 (Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Taxanes)

Precautions:
Fertility warning
Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling
Cytotoxic / special handling

Handle with special care.

Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding
Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis
Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions
Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

Docetaxel is a chemotherapy drug used for the treatment of various types of cancer, including breast cancer, lung cancer, and prostate cancer. It belongs to the taxane class and works by inhibiting cell division, preventing the growth and spread of cancer cells.

The medication is administered intravenously, usually as part of a specific regimen, under the supervision of an oncologist. It is effective in reducing tumor size and prolonging patient survival.

Side effects may include nausea, vomiting, hair loss, neutropenia, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Docetaxel. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about TEDOCAD 20mg / 0.5ml

  • Substance: docetaxel
  • Date of last drug list: 01-07-2013
  • Commercial code: W55993001
  • Concentration: 20mg / 0.5ml
  • Pharmaceutical form: concentrate+solvent for solution for infusion
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for docetaxel

  • 10mg/ml
  • 120mg/6ml
  • 160mg/8ml
  • 20mg
  • 20mg/0.5ml
  • 20mg/1ml
  • 20mg/ml
  • 40mg/ml
  • 80mg
  • 80mg/2ml
  • 80mg/4ml